Evidence that changes in antimicrobial peptides during tuberculosis are related to disease severity, clinical presentation, specific therapy and levels of immune-endocrine mediators

Neuroendocrine Regulation of Immunity

Jeanette I. Webster, Leonardo H. Tonelli, Esther M. Sternberg · Annual Review of Immunology · 2002 · 952 citations

Life Sciences, Immunology, Neuroscience +17

Expression of Cathelicidin LL-37 during<i>Mycobacterium tuberculosis</i>Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells

Bruno Rivas‐Santiago, Rogélio Hernández‐Pando, Claudia Carranza et al. · Infection and Immunity · 2007 · 246 citations · Full text

Life Sciences, Immunology, Microbiology +17

Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment

Annelies Verbon, Nicole P. Juffermans, Sander J. H. van Deventer et al. · Clinical & Experimental Immunology · 1999 · 226 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +8

Human β-Defensin 2 Is Expressed and Associated with<i>Mycobacterium tuberculosis</i>during Infection of Human Alveolar Epithelial Cells

Bruno Rivas‐Santiago, Stephan Schwander, Carmen Sarabia et al. · Infection and Immunity · 2005 · 167 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +10

Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages

Avinash Sonawane, José Carlos Santos, Bibhuti B. Mishra et al. · Cellular Microbiology · 2011 · 162 citations

Life Sciences, Immunology, Infectious Diseases +15